Cleared Special

K201068 - Affinity CP Centrifugal Blood Pump, Affinity CP Centrifugal Blood Pump with Balance Biosurface, Affinity CP Centrifugal Blood Pump with Cortiva BioActive Surface (FDA 510(k) Clearance)

May 2020
Decision
29d
Days
Class 2
Risk

K201068 is an FDA 510(k) clearance for the Affinity CP Centrifugal Blood Pump, Affinity CP Centrifugal Blood Pump with Balance Biosurface, Affinity CP Centrifugal Blood Pump with Cortiva BioActive Surface. This device is classified as a Pump, Blood, Cardiopulmonary Bypass, Non-roller Type (Class II - Special Controls, product code KFM).

Submitted by Medtronic, Inc. (Minneapolis, US). The FDA issued a Cleared decision on May 21, 2020, 29 days after receiving the submission on April 22, 2020.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.4360.

Submission Details

510(k) Number K201068 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 22, 2020
Decision Date May 21, 2020
Days to Decision 29 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Statement

Device Classification

Product Code KFM — Pump, Blood, Cardiopulmonary Bypass, Non-roller Type
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.4360